In human DM1 patient-derived iPSCs, the TALEN system was used to insert of a polyadenylation (polyA) signal upstream of DMPK CTG repeats, leading to premature termination of transcription and elimination of toxic mutant transcripts. This evidence concerns the gene DMPK and myotonic dystrophy type 1.